Julia Tolstova specialises mainly in large and complex domestic and cross-border M&A transactions and capital markets. She also advises clients on all aspects of takeover and corporate law, and corporate governance.
Her clients comprise public and private companies across a broad spectrum of commercial sectors as well as private equity firms.
Matters in which Julia Tolstova acted as counsel include:
Advising Idorsia Ltd (SIX listed) on the issuance and offering of CHF 600 million senior unsecured convertible bonds due 2028 convertible into shares of Idorsia by way of private placement
Advising Meyer Burger Technology AG (SIX listed) on the concurrent private placement of over 155 million newly issued registered shares with a nominal value of CHF 0.05 per share and EUR 145 million green senior unsecured guaranteed convertible bonds due 2027 by way of accelerated book building process
Advising Global Blue and Silverlake as Swiss counsel in its combination with Fair Point Acquisition Corporation, as a result of which Global Blue became a public traded company on the New York Stock Exchange
Advising CRH plc as Swiss counsel on the sale of its European distribution business to private equity funds managed by Blackstone
Advising Électricité de France on the sale of its 25% participation in Alpiq Holding AG (SIX listed) to Primeo Energie (EBM) and EOS Holding
Advising Actelion in connection with the $30 billion public tender offer by Johnson & Johnson to the shareholders of Actelion and the simultaneous demerger of Idorsia from Actelion
Advising BioTelemetry, Inc. (NASDAQ listed) in connection with its competing public tender offer to the shareholders of LifeWatch AG
- Zürcher Anwaltsverband (ZAV)
- New York State Bar Association (NYSBA)
- IBA International Bar Association